Abstract
Ceramide galactosyltransferase (UGT8) is an enzyme that regulates the synthesis of sphingolipids of the myelin sheath in nervous systems. The protein raises an increasing research interest as a potential marker of cancer progression in various organs. In the present study we seek to determine whether UGT8 could play a role of a therapeutic marker in non-small cell lung carcinoma (NSCLC). We addressed the issue by examining the intensity of UGT8 expression in tissue specimens of primary and corresponding metastatic lung tumors in 19 NSCLC patients undergoing surgery. The methodology was one of immunohistochemical tissue staining using light microscopy. The findings were that the majority of both lung primary and metastatic tumor tissues were positive in UGT8 signals. The cytoplasmic expression of UGT8 was found in 68.4 % of cases of primary tumors and 82.2 % of metastases, with a positive correlation between the UGT8 expression in both tumor tissues. The normal tissue adjacent to tumors showed no positive UGT8 staining. However, we failed to find any appreciable difference in UGT8 expression depending on the clinical stage of NSCLC or lymph node involvement. Nor was there any association between UGT8 expression in tumor tissues and patients’ survival time. We conclude that it is unlikely that therapeutic targeting of UGT8 could inhibit cell proliferation and invasion of NSCLC. UGT8, although enhanced in NSCLC tissues, does not meet the criteria of a lung tumor marker. Thus, UGT8 cannot be considered as having diagnostic or therapeutic utility in NSCLC. The pathophysiological meaning of enhanced expression of UGT8 in lung cancer remains to be explored in further studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bosio A, Binczek E, Le Beau MM, Fernald AA, Stoffel W (1996) The human gene CGT encoding the UDP-galactose ceramide galactosyl transferase (cerebroside synthase): cloning, characterization, and assignment to human chromosome 4, band q26. Genomics 34(1):69–75
Dyer CA, Benjamins JA (1989) Organization of oligodendroglial membrane sheets: II. Galactocerebroside: antibody interactions signal changes in cytoskeleton and myelin basic protein. J Neurosci Res 24:212–221
Dzięgiel P, Owczarek T, Plażuk E, Gomułkiewicz A, Majchrzak M, Podhorska-Okołów M, Driouch K, Lidereau R, Ugorski M (2010) Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases. Br J Cancer 103(4):524–531
Jassem J, Biernat W, Drosik K, Dziadziuszko R, Kordek R, Kozielski J, Kowalski DM, Krzakowski M, Nikliński J, Olszewski W, Orłowski T, Ramlau R, Roszkowski-Śliz K, Rzyman W (2010) Updated recommendations on systemic treatment of non-small cell lung cancer and malignant pleural mesothelioma. Pneumol Alergol Pol 78(6):418–431 (Article in Polish)
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) CA Cancer J Clin 61(2):69–90
Kosacka M, Jankowska R (2007) The epidemiology of lung cancer. Pneumol Alergol Pol 75(1):76–80 (Article in Polish)
Kua LF, Ross S, Lee SC, Mimura K, Kono K, Goh BC, Yong WP (2012) UGT1A6 polymorphisms modulated lung cancer risk in a Chinese population. PLoS One 7(8):e42873. doi:10.1371/journal.pone.004287
Lee JA, Liu HE, Huang WI, Lee CN, Yu MC, Bai KJ, Chang JH, Hsu HL, Lu PC, Chen HY (2011) Association of low activity of UGT1A7 with lung cancer in Taiwan: a preliminary case control study. J Food Drug Anal 19(4):403–409
Li CH, To KF, Tong JHM, Xiao Z, Xia T, Lai PBS, Chow SC, Zhu Y-X, Chan SL, Marquez VE, Chen Y (2013) Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin. Gastroenterology 144(5):1086–1097.e9
Liu Y, Chen Y, Momin A, Shaner R, Wang E, Bowen NJ, Matyunina LV, DeEtte WL, McDonald JF, Cameron Sullards M, Merrill AH Jr (2010) Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry. Mol Cancer 9:186. doi:10.1186/1476-4598-9-186
Nakamura Y, Soda H, Oka M, Kinoshita A, Fukuda M, Fukuda M, Takatani H, Nagashima S, Soejima Y, Kasai T, Nakatomi K, Masuda N, Tsukamoto K, Kohno S (2011) Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A1*6 and UGT1A1*27 with severe neutropenia. J Thorac Oncol 6(1):121–127
Nowak M, Dziegiel P, Madej J, Ugorski M (2013) Ceramide galactosyltransferase (UGT8) as a molecular marker of canine mammary tumor malignancy. Folia Histochem Cytobiol 51(2):164–167
Oudes AJ, Roach JC, Walashek LS, Eichner LJ, True LD, Vessella RL, Liu AY (2005) Application of affymetrix array and massively parallel signature sequencing for identification of genes involved in prostate cancer progression. BMC Cancer 5:86
Owczarek TB, Suchanski J, Pula B, Kmiecik AM, Chadalski M, Jethon A, Dziegiel P, Ugorski M (2013) Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule. PLoS One 8(12):e84191. doi:10.1371/journal.pone.0084191
Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8(3):138–140
Ruckhaberle E, Karn T, Rody A, Hanker L, Gätje R, Metzler D, Holtrich U, Kaufmann M (2009) Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer. J Cancer Res Clin Oncol 135(8):1005–1013
Schulte S, Stoffel W (1993) Ceramide UDP galactosyltransferase from myelinating rat-brain: purification, cloning, and expression. Proc Natl Acad Sci U S A 90(21):10265–10269
Sung C, Li J, Pearl D, Coons S, Scheithauer B, Johnson P, Yates A (1995) Glycolipids and myelin proteins in human oligodendrogliomas. J Neurochem 65:S111
Zheng Z, Fang JL, Lazarus P (2002) Glucuronidation: an important mechanism for detoxification of benzo[a] pyrene metabolites in aerodigestive tract tissues. Drug Metab Dispos 30(4):397–403
Acknowledgements
This work was performed as a separate ramification of the project “Intratumoral freezing and dye injection during surgical resection of lung tumors: a new targeted delivery technique”, funded by the statutory budget of Wroclaw Medical University in Poland.
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Rzechonek, A. et al. (2016). Expression of Ceramide Galactosyltransferase (UGT8) in Primary and Metastatic Lung Tissues of Non-Small-Cell Lung Cancer. In: Pokorski, M. (eds) Advancements in Clinical Research. Advances in Experimental Medicine and Biology(), vol 952. Springer, Cham. https://doi.org/10.1007/5584_2016_69
Download citation
DOI: https://doi.org/10.1007/5584_2016_69
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-48032-9
Online ISBN: 978-3-319-48033-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)